Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2974229 | Journal des Maladies Vasculaires | 2015 | 11 Pages |
Abstract
The results of the ArchiMed study support that the thromboprophylaxis treatment with fondaparinux 2.5Â mg in ambulatory general medicine, and the associated medical conditions were usually consistent with the SmPC or guidelines. However, a difference was found for the duration and the initial indication, in situations that may be regarded as presenting a risk by the prescriber.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
I. Mahé, J.-P. Daurès, D. Pouchain, I. Quéré, C. Aubin, J. Doussaint, S. Schück, C. Leroyer,